Medication education
About Ozempic (semaglutide)
Ozempic is a prescription-only, once-weekly injectable medicine containing semaglutide, used in the management of type 2 diabetes. Whether it is appropriate for you is a decision for a qualified doctor after an individual assessment.
- Active ingredient
- Semaglutide
- How it acts
- GLP-1 receptor agonist
- Format
- Once-weekly injection
- Status
- Prescription-only
OverviewWhat Ozempic is
Ozempic is the brand name for an injectable form of semaglutide, a prescription medicine given as a once-weekly injection under the skin.
It acts on the GLP-1 receptor, which is involved in appetite and blood-glucose regulation. Ozempic is approved as a treatment for type 2 diabetes — it is not a general consumer weight-loss product.
How it works, in plain language
Semaglutide activates the GLP-1 receptor. In plain terms, this helps the body release insulin when blood sugar is high, reduce appetite, increase feelings of fullness and slow stomach emptying — supporting blood-glucose regulation in type 2 diabetes.
Approved-use context in India
Semaglutide injection (Ozempic) has been approved in India as an adjunct to diet and exercise to improve blood-glucose control in adults with type 2 diabetes.
Ozempic is distinct from Wegovy, which is a different semaglutide product authorised for chronic weight management. Ozempic is not positioned as a weight-loss medicine, and any use is a doctor's individual decision.
Why individual assessment is required
Ozempic is a prescription-only medicine that is not suitable for everyone. A doctor must review your health, history and any contraindications before it is considered, and it is prescribed for its approved use in type 2 diabetes.
Important factors a doctor may review
- Your medical history and current health, particularly your diabetes management
- Existing medicines and possible interactions, especially other diabetes medicines
- Personal and family history relevant to safety, including any thyroid C-cell tumour history
- Kidney, liver, pancreatic and gallbladder health where relevant
- Any history of diabetic retinopathy (eye disease)
- Pregnancy or reproductive plans
- Whether the potential benefit outweighs the risk for you
Important contraindication categories
Ozempic must not be used in certain situations. A doctor will check for these before considering it:
- A personal or family history of medullary thyroid carcinoma (MTC), or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- A previous serious hypersensitivity (allergic) reaction to semaglutide or any of its components
Important warnings and precautions
- Pancreatitis: inflammation of the pancreas has been reported; seek urgent care for severe, persistent abdominal pain.
- Diabetic retinopathy: rapid improvement in blood glucose has been associated with temporary worsening of diabetic eye disease; tell your doctor about any eye history.
- Hypoglycaemia: the risk of low blood sugar increases when semaglutide is used with insulin or certain other diabetes medicines.
- Dehydration and kidney risk: significant vomiting or diarrhoea can cause dehydration, which may affect kidney function.
- Gallbladder problems: gallstones and related events have been reported.
- Severe gastrointestinal conditions: not recommended in people with severe gastroparesis or severe gastrointestinal disease.
- Thyroid C-cell tumours: seen in animal studies; relevance to humans is uncertain, which is why MTC/MEN2 history matters.
- Planned surgery or procedures involving anaesthesia or deep sedation: tell your care team you take this medicine.
General monitoring
If prescribed, your blood glucose, tolerability, weight and relevant laboratory markers are reviewed over time, and any dose adjustment is made by your treating clinician. Any diabetic-retinopathy history is also considered.
Common side effects
- Nausea, vomiting, diarrhoea or constipation — most common when starting or increasing a dose
- Reduced appetite, indigestion or abdominal discomfort
- Injection-site reactions such as redness or itching
Serious symptoms — seek medical attention
- Severe, persistent abdominal pain (possible pancreatitis)
- Changes in vision, especially if you have diabetic retinopathy
- Signs of a serious allergic reaction, such as swelling of the face or throat, or difficulty breathing
- Persistent vomiting or diarrhoea leading to dehydration
- Symptoms of very low blood sugar if you also take certain diabetes medicines
Pregnancy and reproductive planning
Semaglutide is not recommended during pregnancy. If you are pregnant, planning a pregnancy, or could become pregnant, tell your doctor before any treatment decision — reproductive planning is an explicit part of the clinical review.
If you take other diabetes medicines
Ozempic is itself a diabetes medicine. If you also take insulin or a sulfonylurea, using them together can increase the risk of low blood sugar. Any adjustment to your diabetes medicines must be made by your treating clinician — never on your own.
How the planned Saathya programme may support you
- Doctor-led assessment before any prescription decision
- Diagnostics to inform suitability, where appropriate
- Nutrition and strength support alongside treatment
- Dose and side-effect tracking with care-team escalation
- Ongoing monitoring and maintenance planning
Availability and pricing: Saathya Health is in pre-launch. The availability and pricing of any medication have not been announced, and joining the waitlist does not guarantee a prescription or any specific medicine.
Ozempic — your questions
Sources
The pharmacological and safety information on this page is grounded in regulator-approved prescribing information. India-approval context refers to CDSCO records; non-Indian labels are cited only for general safety context and are not Indian approval evidence.
Join the early-access waitlist
Register your interest in Saathya Health. Joining creates no treatment commitment — eligibility is assessed separately, and it does not guarantee a consultation, a prescription or medicine availability.
Join the Waitlist